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Background:  Threshold crossings of impedance trends detected by implanted devices have been associated with clinically-relevant heart failure 
events, but their long-term prognosis has not been demonstrated.
Methods:  We reviewed 21,217 patients with OptiVol®-enhanced implanted devices that were continuously monitored remotely in the de-identified 
Medtronic CareLink® Discovery Hub (>6months) with cross-referenced mortality data from SSDI up to 4/10 (mean age 68±12 years, 75% male, 
monitored for 19±9 months, 51% CRT-D). Patients were separated in two groups: those with impedance crossings within the initial 6 months (9,340 
pts) and those without. Survival (adjusted for age and gender) was evaluated after this initial 6 month observation period.
Results:  Patients who experienced threshold crossing within the initial 6 months of monitoring had a 2.15-fold increased long-term mortality risk 
(95% confidence interval 1.95-2.38, p<0.0001). Such increased mortality risk remains significant when analyzed within the following subgroups: 
only CRT-D patients (HR 2.23, p<0.0001), only patients without defibrillator shock (HR 2.10, p<0.0001), only patients without device-detected atrial 
fibrillation (HR 2.04, p<0.0001) during the initial 6 months of monitoring.
Conclusions:  Threshold crossing of impedance trends detected by implanted devices is associated with increased mortality risk. Further studies 
are warranted to better approach and manage this high-risk population.
